| scholarly article | Q13442814 |
| P50 | author | Archana Singh-Manoux | Q30000117 |
| Mika Kivimäki | Q37386335 | ||
| Meena Kumari | Q37390225 | ||
| Aline Dugravot | Q40657977 | ||
| Eric J Brunner | Q58438211 | ||
| Martin J. Shipley | Q114314603 | ||
| P2093 | author name string | Alexis Elbaz | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Random-effects models for longitudinal data | Q28279619 | ||
| Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review | Q28755180 | ||
| Obesity: preventing and managing the global epidemic. Report of a WHO consultation | Q29547404 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade | Q29614407 | ||
| The role of inflammation in vascular diseases. | Q30305653 | ||
| Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study | Q33924600 | ||
| Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib | Q34077849 | ||
| Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials | Q34144290 | ||
| Inflammation and rate of cognitive change in high-functioning older adults | Q34187062 | ||
| C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? | Q34265032 | ||
| The processing-speed theory of adult age differences in cognition | Q34392655 | ||
| Extended results of the Alzheimer's disease anti-inflammatory prevention trial | Q35146385 | ||
| Association of C-reactive protein with cognitive impairment | Q35591752 | ||
| Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. | Q35761935 | ||
| Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study | Q37379665 | ||
| Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy | Q37826006 | ||
| Cross‐Linked Fibrin Degradation Products (D‐Dimer), Plasma Cytokines, and Cognitive Decline in Community‐Dwelling Elderly Persons | Q39665811 | ||
| Inflammatory markers and the risk of Alzheimer disease: the Framingham Study | Q40208679 | ||
| Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease | Q43786341 | ||
| High-sensitivity C-reactive protein and cognitive function in older women | Q44200496 | ||
| Inflammatory markers and cognition in well-functioning African-American and white elders | Q46884320 | ||
| Inflammatory proteins in plasma and the risk of dementia: the rotterdam study | Q47591273 | ||
| Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging | Q48511420 | ||
| Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. | Q48647143 | ||
| C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease | Q48796828 | ||
| Serum inflammatory proteins and cognitive decline in older persons. | Q51930816 | ||
| Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. | Q51975386 | ||
| Inflammation markers in relation to cognition in a healthy aging population. | Q52008621 | ||
| Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections. | Q53203252 | ||
| Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. | Q53250180 | ||
| Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study. | Q53302617 | ||
| Cohort Profile: The Whitehall II study | Q57241528 | ||
| Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction | Q81475541 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 486-493 | |
| P577 | publication date | 2014-07-02 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife | |
| P478 | volume | 83 |
| Q57488927 | Association between diets and mild cognitive impairment in adults aged 50 years or older |
| Q92481296 | Association between major surgical admissions and the cognitive trajectory: 19 year follow-up of Whitehall II cohort study |
| Q47718273 | Association of Peripheral Interleukin-6 with Global Cognitive Decline in Non-demented Adults: A Meta-Analysis of Prospective Studies. |
| Q26822410 | Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection |
| Q50332309 | Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies |
| Q92401437 | Changes in sleep duration and 3-year risk of mild cognitive impairment in Chinese older adults |
| Q40221089 | Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population |
| Q34450127 | Cognitive decline after sepsis |
| Q91936284 | Combined associations of hs-CRP and cognitive function with all-cause mortality among oldest-old adults in Chinese longevity areas: a prospective cohort study |
| Q35651383 | Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6. |
| Q37738338 | Dietary pattern, inflammation and cognitive decline: The Whitehall II prospective cohort study |
| Q92392945 | Does Poorer Pulmonary Function Accelerate Arterial Stiffening?: A Cohort Study With Repeated Measurements of Carotid-Femoral Pulse Wave Velocity |
| Q51546643 | Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy. |
| Q36635024 | Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST). |
| Q47229656 | Elevated Markers of Inflammation Are Associated With Longitudinal Changes in Brain Function in Older Adults |
| Q88611012 | Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease |
| Q92667626 | Executive dysfunction in depression in adolescence: the role of inflammation and higher body mass |
| Q26748713 | Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease |
| Q26747585 | Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats |
| Q92756643 | Gamma-oryzanol Prevents LPS-induced Brain Inflammation and Cognitive Impairment in Adult Mice |
| Q30382506 | General intelligence is associated with subclinical inflammation in Nepalese children: A population-based plasma proteomics study. |
| Q38415914 | Glycemic control, inflammation, and cognitive function in older patients with type 2 diabetes |
| Q35677347 | Immune aging, dysmetabolism, and inflammation in neurological diseases |
| Q35787860 | Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife |
| Q61798803 | Inflammation and quality of life in later life: findings from the health, well-being and aging study (SABE) |
| Q58555818 | Inflammation as a central mechanism in Alzheimer's disease |
| Q47968289 | Influence of Flaxseed Lignan Supplementation to Older Adults on Biochemical and Functional Outcome Measures of Inflammation. |
| Q52382173 | Interleukin-6 and Depressive Mood Symptoms: Mediators of the Association Between Childhood Abuse and Cognitive Performance in Middle-Aged Adults. |
| Q40812428 | Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study |
| Q91931109 | Longitudinal associations between diurnal cortisol variation and later-life cognitive impairment |
| Q47926820 | Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia. |
| Q47146884 | Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion |
| Q21131065 | Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease |
| Q90289879 | Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD |
| Q38668100 | Plasma cytokine IL-6 levels and subjective cognitive decline: preliminary findings. |
| Q92354721 | Post-sepsis syndrome - an evolving entity that afflicts survivors of sepsis |
| Q90691768 | Psychophysiological Responses in People Living with Dementia after an Art Gallery Intervention: An Exploratory Study |
| Q41000187 | Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease. |
| Q95840653 | Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway |
| Q47620461 | Structural social relations and cognitive ageing trajectories: evidence from the Whitehall II cohort study |
| Q58799006 | Systemic Inflammation Mediates Age-Related Cognitive Deficits |
| Q92060683 | Systemic inflammation and modifiable risk factors for cognitive impairment in older persons: Findings from a British birth cohort |
| Q94545415 | TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease |
| Q58616645 | The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study |
| Q91763563 | The Cross-sectional and Longitudinal Associations Between IL-6, IL-10, and TNFα and Cognitive Outcomes in the Mayo Clinic Study of Aging |
| Q92224133 | The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study |
| Q33607272 | The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment. |
| Q50669014 | The Independent Role of Inflammation in Physical Frailty among Older Adults with Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease. |
| Q92490369 | The associations between self-reported depression, self-reported chronic inflammatory conditions and cognitive abilities in UK Biobank |
| Q37327398 | The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters |
| Q42370195 | The level of cognitive function and recognition of emotions in older adults |
| Q92332751 | Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice |
Search more.